Ryu SH - Search Results

1

Efficacy of newly discovered DNA aptamers targeting AXL in a lung cancer cell with acquired resistance to Erlotinib.

Hwang JA, Hur JY, Kim Y, Im JH, Jin SH, Ryu SH, Choi CM. Hwang JA, et al. Among authors: ryu sh. Transl Cancer Res. 2021 Feb;10(2):1025-1033. doi: 10.21037/tcr-20-2447. Transl Cancer Res. 2021. PMID: 35116429 Free PMC article.

2

Collapsin response mediator protein-2 inhibits neuronal phospholipase D(2) activity by direct interaction.

Lee S, Kim JH, Lee CS, Kim JH, Kim Y, Heo K, Ihara Y, Goshima Y, Suh PG, Ryu SH. Lee S, et al. Among authors: ryu sh. J Biol Chem. 2002 Feb 22;277(8):6542-9. doi: 10.1074/jbc.M108047200. Epub 2001 Dec 10. J Biol Chem. 2002. PMID: 11741937 Free article.

3

The synthetic chemoattractant peptide, Trp-Lys-Tyr-Met-Val-D-Met, enhances monocyte survival via PKC-dependent Akt activation.

Bae YS, Kim Y, Park JC, Suh PG, Ryu SH. Bae YS, et al. Among authors: ryu sh. J Leukoc Biol. 2002 Feb;71(2):329-38. J Leukoc Biol. 2002. PMID: 11818455

4

Differential activation of formyl peptide receptor signaling by peptide ligands.

Bae YS, Song JY, Kim Y, He R, Ye RD, Kwak JY, Suh PG, Ryu SH. Bae YS, et al. Among authors: ryu sh. Mol Pharmacol. 2003 Oct;64(4):841-7. doi: 10.1124/mol.64.4.841. Mol Pharmacol. 2003. PMID: 14500740

5

Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-like 1.

Kim Y, Lee BD, Kim O, Bae YS, Lee T, Suh PG, Ryu SH. Kim Y, et al. Among authors: ryu sh. J Immunol. 2006 Mar 1;176(5):2969-75. doi: 10.4049/jimmunol.176.5.2969. J Immunol. 2006. PMID: 16493055

6

Ligand profiling and identification technology for searching bioactive ligands.

Baek MC, Kim SJ, Yea K, Kim Y, Lee BD, Kim J, Lee HJ, Kang MH, Choi SK, Kim JI, Lee TG, Suh PG, Ryu SH. Baek MC, et al. Among authors: ryu sh. Proteomics. 2006 Mar;6(6):1741-9. doi: 10.1002/pmic.200500511. Proteomics. 2006. PMID: 16526000

7

An activator of the cAMP/PKA/CREB pathway promotes osteogenesis from human mesenchymal stem cells.

Kim JM, Choi JS, Kim YH, Jin SH, Lim S, Jang HJ, Kim KT, Ryu SH, Suh PG. Kim JM, et al. Among authors: ryu sh. J Cell Physiol. 2013 Mar;228(3):617-26. doi: 10.1002/jcp.24171. J Cell Physiol. 2013. PMID: 22886506

8

Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis.

Lee YJ, Kim IS, Park SA, Kim Y, Lee JE, Noh DY, Kim KT, Ryu SH, Suh PG. Lee YJ, et al. Among authors: ryu sh. Mol Ther. 2013 May;21(5):1004-13. doi: 10.1038/mt.2013.30. Epub 2013 Mar 19. Mol Ther. 2013. PMID: 23511245 Free PMC article.

9

Mechanistic understanding of insulin receptor modulation: Implications for the development of anti-diabetic drugs.

Yunn NO, Kim J, Kim Y, Leibiger I, Berggren PO, Ryu SH. Yunn NO, et al. Among authors: ryu sh. Pharmacol Ther. 2018 May;185:86-98. doi: 10.1016/j.pharmthera.2017.12.005. Epub 2017 Dec 18. Pharmacol Ther. 2018. PMID: 29262294 Review.

10

An aptamer agonist of the insulin receptor acts as a positive or negative allosteric modulator, depending on its concentration.

Yunn NO, Lee J, Lee HS, Oh EJ, Park M, Park S, Jin SY, Shin E, Lee JWY, Kim Y, Bae SS, Ryu SH. Yunn NO, et al. Among authors: ryu sh. Exp Mol Med. 2022 Apr;54(4):531-541. doi: 10.1038/s12276-022-00760-w. Epub 2022 Apr 27. Exp Mol Med. 2022. PMID: 35478209 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

874 results

Search Page

Filters